Pullen Investment Management, LLC Hcw Biologics Inc. Transaction History
Pullen Investment Management, LLC
- $158 Billion
- Q1 2025
A detailed history of Pullen Investment Management, LLC transactions in Hcw Biologics Inc. stock. As of the latest transaction made, Pullen Investment Management, LLC holds 75,116 shares of HCWB stock, worth $499,521. This represents 0.01% of its overall portfolio holdings.
Number of Shares
75,116
Previous 75,116
-0.0%
Holding current value
$499,521
Previous $33.5 Million
36.76%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding HCWB
# of Institutions
16Shares Held
1.16MCall Options Held
0Put Options Held
0-
Avantax Planning Partners, Inc.280KShares$1.86 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA243KShares$1.62 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA237KShares$1.58 Million0.0% of portfolio
-
Cresset Asset Management, LLC Chicago, IL132KShares$877,7330.01% of portfolio
-
J.W. Cole Advisors, Inc.53.4KShares$355,1230.02% of portfolio
About HCW Biologics Inc.
- Ticker HCWB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,833,100
- Market Cap $238M
- Description
- HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal...